^Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (2004). „Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors”.Eur. J. Pharmacol.495 (2–3): 97—102.PMID15249157.doi:10.1016/j.ejphar.2004.05.033.
^Lovell PJ; Bromidge SM; Dabbs S; et al. (2000). „A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phenol (SB-269970)”.J. Med. Chem.43 (3): 342—5.PMID10669560.doi:10.1021/jm991151j.CS1 одржавање: Експлицитна употреба et al. (веза)
^Foong JP, Bornstein JC (2009). „5-HT antagonists NAN-190 and SB 269970 block alpha2-adrenoceptors in the guinea pig”.Neuroreport.20 (3): 325—330.PMID19190523.doi:10.1097/WNR.0b013e3283232caa.